Proteomic and Transcriptomic Analyses of Macrophages with an Increased Resistance to Oxidized Low Density Lipoprotein (oxLDL)-induced Cytotoxicity Generated by Chronic Exposure to oxLDL*

The uptake of oxidized low density lipoprotein (oxLDL) by macrophages leads to foam cell formation and fatty streaks, which represent early sites of potential atheroma development. We developed a cell culture model of chronic oxLDL exposure to determine whether hallmark parameters of oxLDL uptake and cytotoxicity are altered during foam cell formation and to determine changes in protein and mRNA expression that distinguish acute and chronic oxLDL exposure. Although the extent of oxLDL uptake did not change, a resistance to oxLDL-induced cytotoxicity was observed in the chronically exposed cells. Macrophages that have been chronically exposed to oxLDL required a 40% higher concentration of oxLDL to achieve 50% survival in a 48-h treatment relative to macrophages subjected to a single oxLDL exposure. A main feature of the differentially expressed proteome was a series of significantly overexpressed antioxidant and antioxidant-related proteins in the oxLDL-exposed cells. A large proportion of these proteins (45%) was overexpressed in the chronically exposed cells prior to the oxLDL treatment, indicative of the unique phenotype produced by the chronic treatment. Analysis of the transcriptome also revealed a broad increase in the expression of antioxidant and antioxidant-related proteins. In addition, the transcriptome experiments found an increased inflammatory response under conditions of both acute and chronic oxLDL exposure. Overall the combined functional, proteomic, and transcriptomic experiments show that macrophages respond to oxLDL by developing an oxidative stress resistance that increases and stabilizes with chronic exposure. Furthermore this protective response and the increased foam cell survival that it supports amplifies their proatherogenic role by promoting a continued inflammatory state.

[1]  R. Kinobe,et al.  Peroxynitrite-mediated inactivation of heme oxygenases , 2004, BMC pharmacology.

[2]  Peng Yang,et al.  Intercellular adhesion molecule-1 and vascular endothelial growth factor expression kinetics in macrophage-derived foam cells. , 2003, Life sciences.

[3]  G. Ansari,et al.  Methylamine metabolism to formaldehyde by vascular semicarbazide-sensitive amine oxidase. , 1992, Toxicology.

[4]  D. Petersen,et al.  Human carbonyl reductase catalyzes reduction of 4-oxonon-2-enal. , 2004, Biochemistry.

[5]  M. Richard,et al.  Effects of chronic ethanol exposure on acetaldehyde and free radical production by astrocytes in culture. , 2000, Alcohol.

[6]  A. Daoud,et al.  Sequential morphologic studies of regression of advanced atherosclerosis. , 1981, Archives of pathology & laboratory medicine.

[7]  B. Björkerud,et al.  Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[8]  D. Kinden,et al.  Atherosclerosis in Rabbits Fed a Low Cholesterol Dietfor Five Years , 1982, Arteriosclerosis.

[9]  P G Anderson,et al.  Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. , 1994, Biological chemistry Hoppe-Seyler.

[10]  G. Opiteck,et al.  In Vitro Biomarker Discovery for Atherosclerosis by Proteomics* , 2004, Molecular & Cellular Proteomics.

[11]  R. Gerrity,et al.  Ultrastructural identification of monocyte-derived foam cells in fatty streak lesions. , 1980, Artery.

[12]  W. Pearce,et al.  Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: The possible role for IL-6 and interferon-gamma in vascular inflammation , 1994, Agents and Actions.

[13]  N. Sherman,et al.  Protein Sequencing and Identification Using Tandem Mass Spectrometry: Kinter/Tandem Mass Spectrometry , 2000 .

[14]  B. Schreiber,et al.  Role of macrophage‐expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  D. Ross,et al.  A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Pietraforte,et al.  Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma. , 1998, Archives of biochemistry and biophysics.

[17]  Jordi Félez,et al.  Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against α‐Enolase , 2003, American journal of hematology.

[18]  Y. Sun,et al.  Stable H2O2-resistant variants of Chinese hamster fibroblasts demonstrate increases in catalase activity. , 1988, Radiation research.

[19]  D. Steinberg,et al.  Macrophage Oxidation of Low Density Lipoprotein Generates a Modified Form Recognized by the Scavenger Receptor , 1986, Arteriosclerosis.

[20]  D. Harrison,et al.  Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. , 1996, The Journal of clinical investigation.

[21]  G. Favre,et al.  Tamoxifen Is a Potent Inhibitor of Cholesterol Esterification and Prevents the Formation of Foam Cells , 2004, Journal of Pharmacology and Experimental Therapeutics.

[22]  S. Horwitz,et al.  The Microtubule-destabilizing Activity of Metablastin (p19) Is Controlled by Phosphorylation* , 1997, The Journal of Biological Chemistry.

[23]  H. Rus,et al.  Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. , 1996, Atherosclerosis.

[24]  W. Blaner,et al.  9-cis-retinoids: biosynthesis of 9-cis-retinoic acid. , 2000, Biochemistry.

[25]  D. Steinberg,et al.  Enhanced Macrophage Degradation of Biologically Modified Low Density Lipoprotein , 1983, Arteriosclerosis.

[26]  W. Dewey,et al.  Hydrogen peroxide or heat shock induces resistance to hydrogen peroxide in Chinese hamster fibroblasts , 1987, Journal of cellular physiology.

[27]  M. Malinow,et al.  Ultrastructure of experimental coronary artery atherosclerosis in cynomolgus macaques. A comparison with the lesions of other primates. , 1982, Atherosclerosis.

[28]  A. Namane,et al.  Protein sequencing and identification using tandem mass spectrometry. Edited by Michael Kinter, Nicholas E. Sherman, published by Wiley-Interscience Series on Mass Spectrometry, 2000, 301 p. , 2002 .

[29]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[30]  A. Mantovani,et al.  IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. , 2003, Trends in immunology.

[31]  R. Morton,et al.  Lipid Transfer Inhibitor Protein Defines the Participation of High Density Lipoprotein Subfractions in Lipid Transfer Reactions Mediated by Cholesterol Ester Transfer Protein (CETP)* , 2003, Journal of Biological Chemistry.

[32]  E. B. Smith THE INFLUENCE OF AGE AND ATHEROSCLEROSIS ON THE CHEMISTRY OF AORTIC INTIMA. 1. THE LIPIDS. , 1965, Journal of atherosclerosis research.

[33]  M. Brown,et al.  The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. , 1980, Journal of supramolecular structure.

[34]  G. Chisolm,et al.  LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. , 1979, Atherosclerosis.

[35]  C. Cross,et al.  Inactivation of glutathione S-transferases by nitric oxide-derived oxidants: exploring a role for tyrosine nitration. , 2001, Archives of biochemistry and biophysics.

[36]  D. Morel,et al.  Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. , 1983, Journal of lipid research.

[37]  D. Steinberg,et al.  The oxidative modification hypothesis of atherogenesis: an overview. , 2000, Free radical biology & medicine.

[38]  P. Libby,et al.  Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[39]  T. Shimokama,et al.  Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis , 2005, Virchows Archiv A.

[40]  A. Tall,et al.  IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. , 1997, The Journal of clinical investigation.

[41]  A. Nel,et al.  Nitrotyrosine‐modified proteins and oxidative stress induced by diesel exhaust particles , 2005, Electrophoresis.

[42]  H. Fung,et al.  Mechanism-based partial inactivation of glutathione S-transferases by nitroglycerin: tyrosine nitration vs sulfhydryl oxidation. , 2003, Nitric oxide : biology and chemistry.

[43]  F. Spener,et al.  Expression of fatty-acid-binding proteins in cells involved in lung-specific lipid metabolism. , 1998, European journal of biochemistry.

[44]  P. Libby,et al.  Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. , 1992, The American journal of pathology.

[45]  D. Dewitt,et al.  Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. , 1993, The Journal of biological chemistry.

[46]  Terry J. Smith,et al.  Leukoregulin Induction of Prostaglandin-Endoperoxide H Synthase-2 in Human Orbital Fibroblasts , 1996, The Journal of Biological Chemistry.

[47]  D. Dewitt,et al.  Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. , 1995, Seminars in nephrology.

[48]  P. Yu,et al.  Endogenous formaldehyde as a potential factor of vulnerability of atherosclerosis: involvement of semicarbazide-sensitive amine oxidase-mediated methylamine turnover. , 1998, Atherosclerosis.

[49]  M. Daemen,et al.  Identification of Genes Potentially Involved in Rupture of Human Atherosclerotic Plaques , 2001, Circulation research.

[50]  Elspeth B. Smith,et al.  The influence of age and atherosclerosis on the chemistry of aortic intima , 1965 .

[51]  J. Hamilton,et al.  Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[52]  P. Nelson,et al.  Dual-substrate Specificity Short Chain Retinol Dehydrogenases from the Vertebrate Retina* 210 , 2002, The Journal of Biological Chemistry.

[53]  E. B. Smith,et al.  Lipid in the aortic intima. The correlation of morphological and chemical characteristics. , 1967, Journal of atherosclerosis research.

[54]  F. Ursini,et al.  LDL- is a lipid hydroperoxide-enriched circulating lipoprotein. , 1997, Journal of lipid research.

[55]  E. Lubberts,et al.  Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand. , 2002, The American journal of pathology.

[56]  O. Stein,et al.  Macrophage cholesterol efflux to free apoprotein A-I in C3H and C57BL/6 mice. , 2002, Biochemical and biophysical research communications.

[57]  M. N. Hughes,et al.  Interaction of bilirubin and biliverdin with reactive nitrogen species , 2003, FEBS letters.

[58]  C. Selzman,et al.  Interleukin-10 attenuates the response to vascular injury. , 2004, The Journal of surgical research.

[59]  C. Turck,et al.  A role for the actin-bundling protein L-plastin in the regulation of leukocyte integrin function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[60]  S. Glagov,et al.  Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. , 1980, The American journal of pathology.

[61]  James L. Young,et al.  Expression of Interleukin (IL)-18 and Functional IL-18 Receptor on Human Vascular Endothelial Cells, Smooth Muscle Cells, and Macrophages , 2002, The Journal of experimental medicine.

[62]  Gerrity Rg,et al.  Ultrastructural identification of monocyte-derived foam cells in fatty streak lesions. , 1980 .

[63]  F. Bell,et al.  Arterial fatty acid-binding protein activity associated with dietarily-induced and spontaneously occurring atherosclerosis in the rabbit (Oryctolagus cuniculus). , 1990, Comparative biochemistry and physiology. B, Comparative biochemistry.

[64]  M. Salmona,et al.  Protein Nitration in a Mouse Model of Familial Amyotrophic Lateral Sclerosis , 2005, Journal of Biological Chemistry.

[65]  Roland Somogyi,et al.  Large Scale Gene Expression Analysis of Cholesterol-loaded Macrophages* , 2000, The Journal of Biological Chemistry.

[66]  R. Dean,et al.  Regulation of serum-induced lipid accumulation in human monocyte-derived macrophages by interferon-gamma. Correlations with apolipoprotein E production, lipoprotein lipase activity and LDL receptor-related protein expression. , 1997, Atherosclerosis.

[67]  William A. Boisvert,et al.  Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ , 2003, Science.

[68]  Jeffrey B. Boord,et al.  Combined Adipocyte-Macrophage Fatty Acid–Binding Protein Deficiency Improves Metabolism, Atherosclerosis, and Survival in Apolipoprotein E–Deficient Mice , 2004, Circulation.

[69]  C. Argmann,et al.  Activation of Peroxisome Proliferator–Activated Receptor Gamma and Retinoid X Receptor Results in Net Depletion of Cellular Cholesteryl Esters in Macrophages Exposed to Oxidized Lipoproteins , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[70]  F. Bell,et al.  Temporal evaluation of fatty acid-binding protein (FABP) activity in association with the development of atherosclerosis in the rabbit. , 1992, Comparative biochemistry and physiology. Comparative physiology.

[71]  Hyung-Sik Kang,et al.  IL‐6 induces hepatic inflammation and collagen synthesis in vivo , 1994, Clinical and experimental immunology.

[72]  T. Hara,et al.  Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. , 2000, The American journal of pathology.

[73]  S. Park,et al.  Identification of a zeta-crystallin (quinone reductase)-like 1 gene (CRYZL1) mapped to human chromosome 21q22.1. , 1999, Genomics.

[74]  P. Libby,et al.  CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells. , 1999, The American journal of pathology.

[75]  D. Ross,et al.  Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: identification of target cells and a potential role for modulation of apoptosis in benzene toxicity. , 1996, Environmental health perspectives.

[76]  C. Richards,et al.  Oncostatin M Regulates Eotaxin Expression in Fibroblasts and Eosinophilic Inflammation in C57BL/6 Mice1 , 2003, The Journal of Immunology.